Skip to main content

Evidence to Improve Care

Transcatheter Aortic Valve Implantation in Patients With Severe Aortic Valve Stenosis at Low Surgical Risk

Draft Recommendation

  • The Quality business unit at Ontario Health, based on guidance from the Ontario Health Technology Advisory Committee, recommends publicly funding transcatheter aortic valve implantation in patients with severe aortic valve stenosis who are at low surgical risk

Read the draft recommendation report

We want to hear from you.

This topic is now available for public feedback until February 23, 2020. Please feel free to forward this page to any individual you think may be interested in reviewing this assessment. All comments will be considered before a final recommendation is made and posted here.

Use the tabs below to learn more about this topic, download supporting draft documents, including the full assessment report, and submit feedback.

To be notified once a final recommendation is posted here, sign up for our newsletter.


Aortic valve stenosis is a common heart disease. It’s when the aortic valve in the heart has narrowed, causing the heart to work harder to pump blood to the body.

The usual treatment replaces the damaged valve with an artificial one through open-heart surgery -- known as surgical aortic valve replacement. Another option, called transcatheter aortic valve implantation, is a less invasive procedure. This procedure goes through an artery, most commonly in the leg, to place an artificial valve inside the damaged one.

A previous health technology assessment reviewed this procedure for people who are at intermediate risk for surgery (which means at increased risk of dying within 30 days of a surgical valve replacement). This new health technology assessment looks at how safe and effective transcatheter aortic valve implantation is for people at low risk for surgery. We looked at whether this procedure is cost–effective and at the budget impact of publicly funding surgery for people at low risk levels. We also talked with people who have aortic stenosis, their families and caregivers to learn about their experiences, preferences and values.

The assessment was conducted in collaboration with the Canadian Agency for Drugs and Technologies in Health (CADTH). The Agency completed a rapid review of the qualitative evidence of patient preferences.

Read the full health technology assessment report for more information.

Transcatheter Aortic Valve Implantation in Patients With Severe Aortic Valve Stenosis at Low Surgical Risk: A Health Technology Assessment (PDF)
February 2020


Related Resources

Transcatheter Aortic Valve Implantation for Aortic Stenosis: A Rapid Qualitative Review (PDF)
September 2019


Use of this site, and the interpretation of the information contained here, is subject to important terms and conditions. Use of this site and information except in accordance with these terms and conditions is expressly prohibited.

We reviewed evidence on the use of transcatheter aortic valve implantation in patients with severe aortic valve stenosis at low surgical risk. Read the latest draft recommendation and share your feedback.

Submit Feedback


Date posted: February 3, 2020
Closing date for public comment: February 23, 2020




RECEIVE NOTIFICATION OF WHEN OUR DRAFT RECOMMENDATIONS ARE OPEN FOR FEEDBACK

Sign up for our newsletter to receive monthly notifications of when draft recommendations are open for feedback

A senior couple looking at their tablet together

Let’s make our health system healthier

Join Our Patient, Family and Public Advisors Program

Patients, families and the public are central to improving health quality.


Man smiling

Sign up for our newsletter

Are you passionate about quality health care for all Ontarians? Stay in-the-know about our newest programs, reports and news.

Health Quality Connect - Health Quality Ontario's newsletter - on an iPad and a cell phone